Balkan Endemic Nephropathy Risk Associates to the hs1.2 Ig Enhancer Polymorphism

Balkan Endemic Nephropathy (BEN) is a kidney degenerative disease with a high incidence in the valleys of the Danube and tributary rivers. Many studies describe it as a multifactorial disease. Environmental as well immuno-inflammatory and genetic cofactors have been suggested to trigger the onset of...

Full description

Bibliographic Details
Main Authors: D. Frezza, E. Serone, S. Lolli, R. Cianci, P. D'Addabbo, C. Mattioli, V. Giambra, N. Pavlovic, V. Djordjevic, S. Kostic, F. Pandolfi, E. Kostic
Format: Article
Language:English
Published: SAGE Publishing 2012-09-01
Series:European Journal of Inflammation
Online Access:https://doi.org/10.1177/1721727X1201000315
_version_ 1818533264379346944
author D. Frezza
E. Serone
S. Lolli
R. Cianci
P. D'Addabbo
C. Mattioli
V. Giambra
N. Pavlovic
V. Djordjevic
S. Kostic
F. Pandolfi
E. Kostic
author_facet D. Frezza
E. Serone
S. Lolli
R. Cianci
P. D'Addabbo
C. Mattioli
V. Giambra
N. Pavlovic
V. Djordjevic
S. Kostic
F. Pandolfi
E. Kostic
author_sort D. Frezza
collection DOAJ
description Balkan Endemic Nephropathy (BEN) is a kidney degenerative disease with a high incidence in the valleys of the Danube and tributary rivers. Many studies describe it as a multifactorial disease. Environmental as well immuno-inflammatory and genetic cofactors have been suggested to trigger the onset of the disease. Recently, high levels of C-reactive protein were demonstrated in BEN patients. We performed this study to evaluate the possible correlation of BEN with the polymorphism of the Ig heavy chain 3'Regulatory Region enhancer hsl.2 that is related to changes of consensus for trans activators binding within the DNA sequence and probably consequently autoimmune and inflammatory diseases. Therefore, we studied three cohorts: 1) 111 control subjects, 2) 95 BEN patients in dialysis therapy and 3) 133 components of a large family “J” in the same geographical area. The allelic frequencies of hsl.2 of BEN patients and family “J” components had similar decrease frequency of allele *1 and increase of allele *2 in respect to the controls. This trend suggests the association of allele *1 as a protective and allele *2 as a risk component for the disease. The presence of a consensus sequence for NF-Kb in the allele *2 may link the polymorphism to the inflammatory activity of BEN. This study supports the presence of an inflammatory pathway in BEN through the involvement of polymorphic enhancer hsl.2 influencing differently binding complexes and consequently the 3D structure of 3' Regulatory Region of IgH. Our work is the first study that clearly links BEN to a gene involved in the regulation of immune response.
first_indexed 2024-12-11T17:56:23Z
format Article
id doaj.art-aa814704933a4af784947deef8e8c891
institution Directory Open Access Journal
issn 1721-727X
language English
last_indexed 2024-12-11T17:56:23Z
publishDate 2012-09-01
publisher SAGE Publishing
record_format Article
series European Journal of Inflammation
spelling doaj.art-aa814704933a4af784947deef8e8c8912022-12-22T00:56:03ZengSAGE PublishingEuropean Journal of Inflammation1721-727X2012-09-011010.1177/1721727X1201000315Balkan Endemic Nephropathy Risk Associates to the hs1.2 Ig Enhancer PolymorphismD. Frezza0E. Serone1S. Lolli2R. Cianci3P. D'Addabbo4C. Mattioli5V. Giambra6N. Pavlovic7V. Djordjevic8S. Kostic9F. Pandolfi10E. Kostic11 Department of Biology “Enrico Calef”, University of Roma Tor Vergata, Rome, Italy Department of Biology “Enrico Calef”, University of Roma Tor Vergata, Rome, Italy Institute of Internal Medicine, Catholic University of Sacred Heart, Rome, Italy Institute of Internal Medicine, Catholic University of Sacred Heart, Rome, Italy Department of Biology, University of Bari, Bari, Italy Department of Biology “Enrico Calef”, University of Roma Tor Vergata, Rome, Italy Terry Fox Laboratory, BC Cancer Agency, Vancouver, Canada Clinic for Nephrology, Clinical Center Nis, University of Nis, Serbia Clinic for Nephrology, Clinical Center Nis, University of Nis, Serbia Clinic for Nephrology, Clinical Center Nis, University of Nis, Serbia Institute of Internal Medicine, Catholic University of Sacred Heart, Rome, Italy Clinic for Nephrology, Clinical Center Nis, University of Nis, SerbiaBalkan Endemic Nephropathy (BEN) is a kidney degenerative disease with a high incidence in the valleys of the Danube and tributary rivers. Many studies describe it as a multifactorial disease. Environmental as well immuno-inflammatory and genetic cofactors have been suggested to trigger the onset of the disease. Recently, high levels of C-reactive protein were demonstrated in BEN patients. We performed this study to evaluate the possible correlation of BEN with the polymorphism of the Ig heavy chain 3'Regulatory Region enhancer hsl.2 that is related to changes of consensus for trans activators binding within the DNA sequence and probably consequently autoimmune and inflammatory diseases. Therefore, we studied three cohorts: 1) 111 control subjects, 2) 95 BEN patients in dialysis therapy and 3) 133 components of a large family “J” in the same geographical area. The allelic frequencies of hsl.2 of BEN patients and family “J” components had similar decrease frequency of allele *1 and increase of allele *2 in respect to the controls. This trend suggests the association of allele *1 as a protective and allele *2 as a risk component for the disease. The presence of a consensus sequence for NF-Kb in the allele *2 may link the polymorphism to the inflammatory activity of BEN. This study supports the presence of an inflammatory pathway in BEN through the involvement of polymorphic enhancer hsl.2 influencing differently binding complexes and consequently the 3D structure of 3' Regulatory Region of IgH. Our work is the first study that clearly links BEN to a gene involved in the regulation of immune response.https://doi.org/10.1177/1721727X1201000315
spellingShingle D. Frezza
E. Serone
S. Lolli
R. Cianci
P. D'Addabbo
C. Mattioli
V. Giambra
N. Pavlovic
V. Djordjevic
S. Kostic
F. Pandolfi
E. Kostic
Balkan Endemic Nephropathy Risk Associates to the hs1.2 Ig Enhancer Polymorphism
European Journal of Inflammation
title Balkan Endemic Nephropathy Risk Associates to the hs1.2 Ig Enhancer Polymorphism
title_full Balkan Endemic Nephropathy Risk Associates to the hs1.2 Ig Enhancer Polymorphism
title_fullStr Balkan Endemic Nephropathy Risk Associates to the hs1.2 Ig Enhancer Polymorphism
title_full_unstemmed Balkan Endemic Nephropathy Risk Associates to the hs1.2 Ig Enhancer Polymorphism
title_short Balkan Endemic Nephropathy Risk Associates to the hs1.2 Ig Enhancer Polymorphism
title_sort balkan endemic nephropathy risk associates to the hs1 2 ig enhancer polymorphism
url https://doi.org/10.1177/1721727X1201000315
work_keys_str_mv AT dfrezza balkanendemicnephropathyriskassociatestothehs12igenhancerpolymorphism
AT eserone balkanendemicnephropathyriskassociatestothehs12igenhancerpolymorphism
AT slolli balkanendemicnephropathyriskassociatestothehs12igenhancerpolymorphism
AT rcianci balkanendemicnephropathyriskassociatestothehs12igenhancerpolymorphism
AT pdaddabbo balkanendemicnephropathyriskassociatestothehs12igenhancerpolymorphism
AT cmattioli balkanendemicnephropathyriskassociatestothehs12igenhancerpolymorphism
AT vgiambra balkanendemicnephropathyriskassociatestothehs12igenhancerpolymorphism
AT npavlovic balkanendemicnephropathyriskassociatestothehs12igenhancerpolymorphism
AT vdjordjevic balkanendemicnephropathyriskassociatestothehs12igenhancerpolymorphism
AT skostic balkanendemicnephropathyriskassociatestothehs12igenhancerpolymorphism
AT fpandolfi balkanendemicnephropathyriskassociatestothehs12igenhancerpolymorphism
AT ekostic balkanendemicnephropathyriskassociatestothehs12igenhancerpolymorphism